MedMen Enterprises Inc. (MMEN)

MedMen Enterprises Inc. (MMEN $0.02)
- $0.02 Cap: $22M
- View MMEN Profile
- View Questions on MMEN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Organigram Global Inc. (OGI $2.01)
- $2.01 Cap: $278M
- View OGI Profile
- View Questions on OGI
Aphria Inc. (APHA $16.55)
- $16.55 Cap: $12.08B
- View APHA Profile
- View Questions on APHA
MedMen Enterprises Inc. (MMEN $0.02)
- $0.02 Cap: $22M
- View MMEN Profile
- View Questions on MMEN
Curaleaf Holdings Inc. Subordinate Voting Shares (CURA)
- Cap: $3.73B
- View CURA Profile
- View Questions on CURA

Q: Hello Peter,
With the US elections and the senate win by the democrats, I was expecting that the US cannabis stocks would surge alot more than the Canadian ones. However, this is not the case and am wondering what that is.. For example. if you look at Aphria and Tilray, and Organirams, they have surged alot more than companies that are actually making money like Curaleaf in the USA .. Do you think this is because US companies are not surging as much due to them being on CDNX (not on TSX or NYSE) and may not be readily available for US investors..Also, can you comment on why Medmen is going through the roof in the last 5 days..? thanks very much

Read Answer Asked by umedali on February 09, 2021